Screening and characterization of mutations in isoniazid-resistant Mycobacterium tuberculosis isolates obtained in Brazil


Autoria(s): Cardoso, R. F.; Cooksey, R. C.; Morlock, G. P.; Barco, P.; Cecon, L.; Forestiero, F.; Leite, CQF; Sato, D. N.; Shikama, M. D.; Mamizuka, E. M.; Hirata, RDC; Hirata, M. H.
Contribuinte(s)

Universidade Estadual Paulista (UNESP)

Data(s)

20/05/2014

20/05/2014

01/09/2004

Resumo

We investigated mutations in the genes katG, inhA (regulatory and structural regions), and kasA and the oxyR-ahpC intergenic region of 97 isoniazid (INH)-resistant and 60 INH-susceptible Mycobacterium tuberculosis isolates obtained in two states in Brazil: São Paulo and Parana. PCR-single-strand conformational polymorphism (PCR-SSCP) was evaluated for screening mutations in regions of prevalence, including codons 315 and 463 of katG, the regulatory region and codons 16 and 94 of inhA, kasA, and the oxyR-ahpC intergenic region. DNA sequencing of PCR amplicons was performed for all isolates with altered PCR-SSCP profiles. Mutations in katG were found in 83 (85.6%) of the 97 INH-resistant isolates, including mutations in codon 315 that occurred in 60 (61.9%) of the INH-resistant isolates and 23 previously unreported katG mutations. Mutations in the inhA promoter region occurred in 25 (25.8%) of the INH-resistant isolates; 6.2% of the isolates had inhA structural gene mutations, and 10.3% had mutations in the oxyR-ahpC intergenic region (one, nucleotide -48, previously unreported). Polymorphisms in the kasA gene occurred in both INH-resistant and INH-susceptible isolates. The most frequent polymorphism encoded a G(269)A substitution. Although KatG(315) substitutions are predominant, novel mutations also appear to be responsible for INH resistance in the two states in Brazil. Since ca. 90.7% of the INH-resistant isolates had mutations identified by SSCP electrophoresis, this method may be a useful genotypic screen for INH resistance.

Formato

3373-3381

Identificador

http://dx.doi.org/10.1128/AAC.48.9.3373-3381.2004

Antimicrobial Agents and Chemotherapy. Washington: Amer Soc Microbiology, v. 48, n. 9, p. 3373-3381, 2004.

0066-4804

http://hdl.handle.net/11449/37226

10.1128/AAC.48.9.3373-3381.2004

WOS:000223625800024

WOS000223625800024.pdf

Idioma(s)

eng

Publicador

Amer Soc Microbiology

Relação

Antimicrobial Agents and Chemotherapy

Direitos

openAccess

Tipo

info:eu-repo/semantics/article